Sound and Music for Mild Cognitive Impairment

Sponsor
Johns Hopkins University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05064007
Collaborator
(none)
27
1
3
33.9
0.8

Study Details

Study Description

Brief Summary

Emerging studies in humans found that 40 Hz sound induces neural gamma oscillation and enhanced cognitive function in older adults with and without Alzheimer's Disease. We will compare a 40 Hz music intervention to both 40 Hz sound and music alone in a clinical cohort of older adults with mild cognitive impairment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: A: 40 Hz music
  • Behavioral: B: 40 Hz sound
  • Behavioral: C: Preferred music
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
27 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Power of Sound and Music Interventions for Older Adults With Mild Cognitive Impairment
Actual Study Start Date :
Dec 5, 2021
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

this group will be exposed to condition A first, then B, and C

Behavioral: A: 40 Hz music
The participant will listen to the 40 Hz music playlist one hour each day, 5 days a week for 4 weeks

Behavioral: B: 40 Hz sound
The participant will listen to the 40 Hz sound playlist one hour each day, 5 days a week for 4 weeks

Behavioral: C: Preferred music
The participant will listen to the preferred music playlist one hour each day, 5 days a week for 4 weeks

Experimental: 2

this group will be exposed to condition B first, then C, and A

Behavioral: A: 40 Hz music
The participant will listen to the 40 Hz music playlist one hour each day, 5 days a week for 4 weeks

Behavioral: B: 40 Hz sound
The participant will listen to the 40 Hz sound playlist one hour each day, 5 days a week for 4 weeks

Behavioral: C: Preferred music
The participant will listen to the preferred music playlist one hour each day, 5 days a week for 4 weeks

Experimental: 3

this group will be exposed to condition C first, then A, and B

Behavioral: A: 40 Hz music
The participant will listen to the 40 Hz music playlist one hour each day, 5 days a week for 4 weeks

Behavioral: B: 40 Hz sound
The participant will listen to the 40 Hz sound playlist one hour each day, 5 days a week for 4 weeks

Behavioral: C: Preferred music
The participant will listen to the preferred music playlist one hour each day, 5 days a week for 4 weeks

Outcome Measures

Primary Outcome Measures

  1. Change in Cognitive function [Baseline and immediately after the 4-week intervention]

    Cogstate computerized assessment will be used to measure cognitive function. Higher score represents better cognitive function

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Community-dwelling

  2. amnesia mild cognitive impairment

  3. Preserved function

  4. No dementia

Exclusion Criteria:
  1. known diagnosis of schizophrenia or Parkinson's disease;

  2. severe hearing impairment;

  3. presence of an acute medical or psychiatric condition which would interfere with the subject's ability to follow the study protocol realistically

Contacts and Locations

Locations

Site City State Country Postal Code
1 Johns Hopkins School of Nursing Baltimore Maryland United States 21205

Sponsors and Collaborators

  • Johns Hopkins University

Investigators

  • Principal Investigator: JUNXIN LI, PhD, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT05064007
Other Study ID Numbers:
  • IRB00295386
First Posted:
Oct 1, 2021
Last Update Posted:
Jan 5, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2022